Bionime Corporation (TPE:4737)

Market Cap	3.96B +27.8%
Revenue (ttm)	1.84B -4.9%
Net Income	-180.28M
EPS	-2.68
Shares Out	67.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	124,628
Average Volume	177,840
Open	58.80
Previous Close	58.50
Day's Range	58.30 - 59.50
52-Week Range	50.30 - 73.90
Beta	-0.09
RSI	39.31
Earnings Date	May 8, 2026

About Bionime

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offers blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the prov...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Employees: 500
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4737

Financial Performance

In 2025, Bionime's revenue was 1.84 billion, a decrease of -4.92% compared to the previous year's 1.93 billion. Losses were -180.28 million, 41.7% more than in 2024.